Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;174(12):W114-W115.
doi: 10.7326/L21-0600. Epub 2021 Oct 5.

Update Alert 2: Remdesivir for Adults With COVID-19

Anjum S Kaka  1 , Roderick MacDonald  2 , Eric J Linskens  2 , Timothy J Wilt  3
Affiliations

Update Alert 2: Remdesivir for Adults With COVID-19

Anjum S Kaka et al. Ann Intern Med. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L21-0600.

Update of

References

    1. Wilt TJ , Kaka AS , MacDonald R , et al. Remdesivir for adults with COVID-19: a living systematic review for American College of Physicians practice points. Ann Intern Med. 2021;174:209-220. [PMID: ] doi: 10.7326/M20-5752 - DOI - PMC - PubMed
    1. Kaka AS , MacDonald R , Greer N , et al. Major update: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians practice points. Ann Intern Med. 2021;174:663-672. [PMID: ] doi: 10.7326/M20-8148 - DOI - PMC - PubMed
    1. Kaka A, MacDonald R, Greer N, et al. Surveillance update–02/08/21. Ann Intern Med. 10 February 2021. Accessed at https://www.acpjournals.org/doi/10.7326/M20-8148 on 19 August 2021.
    1. Kaka AS , MacDonald R , Linskens EJ , et al. Update alert: remdesivir for adults with COVID-19 [Letter]. Ann Intern Med. 2021;174:W65. [PMID: ] doi: 10.7326/L21-0375 - DOI - PMC - PubMed
    1. Barratt-Due A , Olsen IC , Nezvalova-Henriksen K , et al; NOR-Solidarity trial. Evaluation of the effects of remdesivir and hydroxychloroquine on viral clearance in COVID-19: a randomized trial. Ann Intern Med. 2021;174:1261-1269. [PMID: ] doi: 10.7326/M21-0653 - DOI - PMC - PubMed

MeSH terms